Concepedia

Author

Espen B. Ellingsen

Oslo University HospitalORCID

Also Known As

E. Ellingsen, Espen B. Ellingsen, Espen Basmo Ellingsen, Espen Basmo. Ellingsen, Espen Ellingsen

55

Publications

298

Citations

8

H-Index

16

Concepts

All Affiliations

Oslo University HospitalUltimovacs (Norway)University of OsloScience for Life LaboratoryUppsala University
EB

About

Espen B. Ellingsen is an author at Oslo University Hospital specializing in genetics, public health, and bioinformatics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

15

2

Public Health

1

1

15

3

Molecular Genetics

1

1

15

4

Molecular Medicine

1

1

15

5

Pathology

1

1

15

Espen B. Ellingsen

×

7

Publications

247

Citations

7

H-Index

YearCitations

Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.

Espen B. Ellingsen, Siegfried Morath, Trude Helen Flo,

PubMed

2002

89

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

Elin Aamdal, Else Marit Inderberg, Espen B. Ellingsen,

Frontiers in Immunology

2021

40

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Espen B. Ellingsen, Elin Aamdal, Tormod Kyrre Guren,

Journal for ImmunoTherapy of Cancer

2022

36

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial

Espen B. Ellingsen, Steven O’Day, Artur Mezheyeuski,

Clinical Cancer Research

2023

25

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma

Vilde Drageset Haakensen, Anna K. Nowak, Espen B. Ellingsen,

Journal of Translational Medicine

2021

23

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

Espen B. Ellingsen, Gergana Bounova, Iliana Kerzeli,

Journal of Translational Medicine

2022

19

Personalized <scp>HLA</scp> typing leads to the discovery of novel <scp>HLA</scp> alleles and tumor‐specific <scp>HLA</scp> variants

Irantzu Anzar, Angelina Sverchkova, Pubudu Samarakoon,

HLA

2022

15

Page 1